Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5270016
Max Phase: Preclinical
Molecular Formula: C41H47N3O17
Molecular Weight: 853.83
Associated Items:
ID: ALA5270016
Max Phase: Preclinical
Molecular Formula: C41H47N3O17
Molecular Weight: 853.83
Associated Items:
Canonical SMILES: CNC(=O)[C@@H](C)NC(=O)c1c(C)cc2c(c1O)-c1c(cc3c(c1O)C(=O)c1cc(OC)cc(O)c1C3=O)[C@H](O)[C@H]2O[C@@H]1O[C@H](C)[C@H](NC)[C@H](O[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O
Standard InChI: InChI=1S/C41H47N3O17/c1-12-7-19-25(32(51)22(12)39(56)44-13(2)38(55)43-5)24-17(10-18-26(33(24)52)29(48)16-8-15(57-6)9-20(45)23(16)28(18)47)30(49)36(19)60-41-35(54)37(27(42-4)14(3)59-41)61-40-34(53)31(50)21(46)11-58-40/h7-10,13-14,21,27,30-31,34-37,40-42,45-46,49-54H,11H2,1-6H3,(H,43,55)(H,44,56)/t13-,14-,21-,27+,30+,31+,34-,35-,36+,37+,40+,41+/m1/s1
Standard InChI Key: VANOHTYKXIEDHU-CGWZNCMFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 853.83 | Molecular Weight (Monoisotopic): 853.2905 | AlogP: -0.95 | #Rotatable Bonds: 9 |
Polar Surface Area: 312.36 | Molecular Species: BASE | HBA: 18 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 7.00 | CX Basic pKa: 8.97 | CX LogP: 0.10 | CX LogD: 0.19 |
Aromatic Rings: 3 | Heavy Atoms: 61 | QED Weighted: 0.10 | Np Likeness Score: 1.45 |
1. Miyanishi W, Ojika M, Akase D, Aida M, Igarashi Y, Ito Y, Nakagawa Y.. (2021) d-Mannose binding, aggregation property, and antifungal activity of amide derivatives of pradimicin A., 55 [PMID:34973516] [10.1016/j.bmc.2021.116590] |
Source(1):